Explore

Rapid ReadRapid Read
Medicare Prescription Payment Plan Offers Monthly Payment Option for Drug Costs

Medicare Prescription Payment Plan Offers Monthly Payment Option for Drug Costs

Medicare has introduced the Medicare Prescription Payment Plan (M3P), allowing eligible members to distribute their out-of-pocket prescription drug costs into monthly payments throughout the year. This initiative aims to help beneficiaries manage their medication expenses more effectively. The amount individuals pay for their medications is influenced by several factors, including their specific health plan, the types of medications they take, whether they qualify for Extra Help (Low-Income Subsidy), and their current stage within the prescription drug coverage year. Understanding these variables, along with terms like deductibles, copays, coinsurance, formularies, and drug tiers, is crucial for beneficiaries to make informed decisions about their coverage and avoid unexpected costs. Each plan's specific costs can vary, making it important for members to review their plan's Prescription Drug Coverage page for detailed information on deductibles, copays, coverage stages, and formulary details.
Rapid ReadRapid Read
Medicare Annual Enrollment Period Offers Beneficiaries Opportunity to Review and Change Coverage

Medicare Annual Enrollment Period Offers Beneficiaries Opportunity to Review and Change Coverage

Medicare's Annual Enrollment Period, also known as Open Enrollment, occurs annually from October 15 to December 7. During this critical window, Medicare beneficiaries have the opportunity to review their existing healthcare coverage and make various changes for the upcoming year. Even if satisfied with their current plans, it is important for beneficiaries to understand potential alterations in plan premiums, benefits, provider networks, prescription drug coverage, formularies, and out-of-pocket costs, as these can change year-to-year. Beneficiaries can switch between Medicare Advantage plans, move from Original Medicare to Medicare Advantage, or return to Original Medicare from an Advantage plan. Additionally, they can join, switch, or drop a Medicare Part D prescription drug plan. Changes made during this period typically become effective on January 1 of the following year.
Rapid ReadRapid Read
CMS Finalizes Guidelines for Medicare Drug Price Negotiation Program, Permanent by 2029

CMS Finalizes Guidelines for Medicare Drug Price Negotiation Program, Permanent by 2029

The Centers for Medicare & Medicaid Services (CMS) has finalized the guidelines for the Medicare Drug Price Negotiation Program, which is set to become a permanent fixture starting in 2029. This program, established by the Inflation Reduction Act of 2022, empowers CMS to directly negotiate drug prices with manufacturers for high-cost medications covered under Medicare's Part B and Part D programs. Under the finalized rule, CMS will identify and publish a list of up to 20 selected drugs for negotiation or renegotiation. The agency will then enter into agreements with participating manufacturers to establish maximum fair prices for these drugs and will publish these agreed-upon prices. The program also includes provisions for imposing civil monetary penalties when necessary. This initiative aims to reduce the cost of prescription drugs for Medicare beneficiaries, though it will not apply to all drugs, take immediate effect, or eliminate all differences between Medicare plans. The implementation of this progr...
TrendlineTrendline
Medicare's Maximum Fair Prices Influence Payer Negotiations and Manufacturer Strategies

Medicare's Maximum Fair Prices Influence Payer Negotiations and Manufacturer Strategies

Medicare's Maximum Fair Prices Influence Payer Negotiations and Manufacturer Strategies
TrendlineTrendline
Humana Seeks Medicare Field Sales Representatives in North Houston to Expand Market Reach

Humana Seeks Medicare Field Sales Representatives in North Houston to Expand Market Reach

Humana Seeks Medicare Field Sales Representatives in North Houston to Expand Market Reach
ReutersReuters
CVS says GLP-1s save money when priced below $350 per month

CVS says GLP-1s save money when priced below $350 per month

By Amina Niasse NEW YORK, Nov 14 (Reuters) - CVS Health said employers and other health plan sponsors could break even on GLP-1 drugs if they are priced below $350 per month as reduced use of medical services, such as hospitalizations and emergency room visits, lower spending enough to offset drug
Rapid ReadRapid Read
Low-Income Seniors Reduce Prescription Spending Due to Cost Sharing, Regardless of Medical Benefit

Low-Income Seniors Reduce Prescription Spending Due to Cost Sharing, Regardless of Medical Benefit

A study published in the November 2026 issue of the American Economic Journal: Economic Policy, authored by economist Christopher Hollrah, reveals that low-income seniors significantly reduce their prescription spending when faced with higher out-of-pocket costs, irrespective of the medical benefit of the drugs. Hollrah examined Medicare's Low-Income Subsidy, which typically limits copays to a few dollars. By comparing similar patients who either retained or lost this subsidy due to Medicaid eligibility timing rules, the study found that losing the subsidy led to a 40 percent reduction in prescription spending and a 16 percent decrease in the quantity of prescriptions filled. The analysis showed that patients economized on higher-priced drugs, with 60 percent of the spending reduction coming from high-benefit prescriptions, compared to 15 percent from lower-benefit ones. For example, insulin purchases, which cost approximately $70 per fill without the subsidy, dropped by 35 percent. The study concluded tha...
TrendlineTrendline
Humana Seeks Medicare Field Sales Representatives in South Houston to Expand Market Presence

Humana Seeks Medicare Field Sales Representatives in South Houston to Expand Market Presence

Humana Seeks Medicare Field Sales Representatives in South Houston to Expand Market Presence
Rapid ReadRapid Read
Massachusetts Faces Escalating Healthcare Costs, Urges Third Major Reform Focused on Prevention

Massachusetts Faces Escalating Healthcare Costs, Urges Third Major Reform Focused on Prevention

Massachusetts is confronting a significant challenge with rising healthcare costs and affordability issues, despite its history of leading national healthcare reforms. The state's healthcare spending reached $83.3 billion in 2024, or $11,663 per resident, marking a 5.7% increase against a 3.6% target. This is the fourth consecutive year the state has missed its spending benchmark. Family premiums for employer coverage have hit $28,151, the highest in the country, with total family healthcare costs, including out-of-pocket expenses, reaching $32,469. Projections from the Health Policy Commission indicate that family premiums could soar to $50,000 by 2032 if current growth rates persist. Approximately two in five residents report difficulty affording care, and federal Medicaid changes are expected to double the state's uninsured rate. This situation highlights a critical need for a new wave of reform, shifting focus from coverage and cost control to illness prediction and prevention.
TrendlineTrendline
U.S. Employers Face Steep Health Benefit Cost Increases for 2027, Driving Cost-Cutting Measures

U.S. Employers Face Steep Health Benefit Cost Increases for 2027, Driving Cost-Cutting Measures

U.S. Employers Face Steep Health Benefit Cost Increases for 2027, Driving Cost-Cutting Measures
TrendlineTrendline
Blue Cross and Blue Shield of Oklahoma Offers 20% Discount on Thorne Supplements

Blue Cross and Blue Shield of Oklahoma Offers 20% Discount on Thorne Supplements

Blue Cross and Blue Shield of Oklahoma Offers 20% Discount on Thorne Supplements
TrendlineTrendline
Retirement Planning Emphasizes Budgeting, Investment Review, and Benefit Understanding for Seniors

Retirement Planning Emphasizes Budgeting, Investment Review, and Benefit Understanding for Seniors

Retirement Planning Emphasizes Budgeting, Investment Review, and Benefit Understanding for Seniors